Sign up
Log in
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Share
Listen to the news

Gainers

  • Protagenic Therapeutics (NASDAQ:PTIX) shares moved upwards by 179.6% to $0.63 during Thursday's pre-market session. The company's market cap stands at $4.5 million. The company's, Q4 earnings came out 3 days ago.
  • Aptevo Therapeutics (NASDAQ:APVO) stock increased by 122.46% to $3.07. The company's market cap stands at $4.4 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock increased by 62.76% to $5.29. The company's market cap stands at $3.2 million.
  • OSR Holdings (NASDAQ:OSRH) stock moved upwards by 44.95% to $2.13. The company's market cap stands at $41.0 million.
  • Genprex (NASDAQ:GNPX) stock increased by 21.08% to $0.36. The company's market cap stands at $3.0 million.
  • Longevity Health Holdings (NASDAQ:XAGE) stock rose 13.64% to $0.15. The market value of their outstanding shares is at $4.5 million.

Losers

  • RxSight (NASDAQ:RXST) stock fell 29.2% to $18.49 during Thursday's pre-market session. The market value of their outstanding shares is at $748.7 million.
  • bioAffinity Technologies (NASDAQ:BIAF) shares fell 24.18% to $0.67. The market value of their outstanding shares is at $10.5 million. As per the news, the Q4 earnings report came out 3 days ago.
  • Aldeyra Therapeutics (NASDAQ:ALDX) stock fell 23.01% to $4.1. The market value of their outstanding shares is at $244.1 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock fell 22.95% to $0.23. The company's market cap stands at $4.6 million.
  • ITeos Therapeutics (NASDAQ:ITOS) stock fell 20.11% to $4.61. The market value of their outstanding shares is at $176.0 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock fell 19.56% to $1.81. The market value of their outstanding shares is at $4.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.